Quarterly report pursuant to Section 13 or 15(d)

ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.20.2
ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)
 6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
Schedule of changes in derivative liability

The following presents changes in the derivative liability through June 30, 2020:

 

    Six Months Ended
    June 30, 2020   June 30, 2019
Beginning Balance   $ 24,767,000     $ 11,917,000  
Conversion to note payable     (19,291,000 )     —    
Change  in fair value recognized in earnings     (5,476,000 )     2,619,000  
Ending Balance   $ —       $ 14,536,000  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following table presents: 1) instruments that were dilutive for the three months ended June 30, 2019 and the six months ended June 30, 2020 and included in the diluted earnings per share, and 2) instruments that were anti-dilutive for the three months ended June 30, 2020 and six months ended June 30, 2019 and excluded from diluted earnings per share as they would have been anti-dilutive::

 

    For the Three Months ended   For the Six Months ended
                 
    June 30,   June 30,   June 30,   June 30,
    2020   2019   2020   2019
                 
    Instruments   Instruments   Instruments   Instruments
    Excluded in   Included in   Included in   Excluded in
    Diluted EPS   Diluted EPS   Diluted EPS   Diluted EPS
                                 
Convertible notes and accrued interest     101,091,766       95,955,013       101,091,766       95,955,013  
Convertible preferred stock - Series B     11,818,181       11,818,181       11,818,181       11,818,181  
Stock options and warrants     173,282,235       183,896,134       173,201,523       177,534,870